WallStreetZenWallStreetZen

NASDAQ: HBIO
Harvard Bioscience Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Harvard Bioscience earnings were -$57.4M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest HBIO earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.3M, down 95.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HBIO reported annual earnings of -$12.4M, with 263.3% growth.

HBIO earnings history

Current Revenue
$88.8M
Current Earnings
-$57.4M
Current Profit Margin
-64.7%

HBIO Return on Equity

Current Company
-144.2%
Current Industry
10%
Current Market
26.6%
HBIO's Return on Equity (-144.2%)... subscribe to Premium to read more.
High Return on Equity Performance

HBIO undefined

Current Company
-55%
Current Industry
8.3%
HBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HBIO announces earnings.

HBIO undefined

Current Company
-215.53%
Current Industry
10.7%
HBIO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HBIO vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HBIO-$46.80M-$57.41MN/A-$1.29
CUPR-$1.13M-$1.19MN/A-$0.07
BNGO-$60.90M-$74.33MN/A-$42.07
NXGL-$2.29M-$2.92MN/A-$0.40
RVP-$829.42k-$8.97MN/A-$0.29
View Top Medical Stocks

Harvard Bioscience Earnings Reports & History FAQ

What were Harvard Bioscience's earnings last quarter?

On HBIO's earnings call on Invalid Date, Harvard Bioscience (NASDAQ: HBIO) reported Q2 2025 earnings per share (EPS) of -$0.05, up 28.57% year over year. Total HBIO earnings for the quarter were -$2.28 million. In the same quarter last year, Harvard Bioscience's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Harvard Bioscience stock.

Is Harvard Bioscience profitable or losing money?

As of the last Harvard Bioscience earnings report, Harvard Bioscience is currently losing money. Harvard Bioscience's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$57.41 million, a 437.61% increase year over year.

What was HBIO's earnings growth in the past year?

As of Harvard Bioscience's earnings date in Invalid Date, Harvard Bioscience's earnings has grown year over year. HBIO earnings in the past year totalled -$57.41 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.